1-8 of 8
Authors: Stéphane de Wit
Journal Article
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2361–2365, https://doi.org/10.1093/jac/dkad247
Published: 04 August 2023
Journal Article
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 9, September 2021, Pages 2380–2393, https://doi.org/10.1093/jac/dkab158
Published: 13 June 2021
Journal Article
Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 6, June 2020, Pages 1618–1622, https://doi.org/10.1093/jac/dkaa056
Published: 25 March 2020
Journal Article
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen Free
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1352–1360, https://doi.org/10.1093/jac/dkv465
Published: 28 January 2016
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART Free
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment Open Access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 2, February 2011, Pages 265–272, https://doi.org/10.1093/jac/dkq458
Published: 31 December 2010
Journal Article
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 3, March 2010, Pages 548–555, https://doi.org/10.1093/jac/dkp479
Published: 05 January 2010
Journal Article
Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 6, December 2009, Pages 1341–1344, https://doi.org/10.1093/jac/dkp366
Published: 14 October 2009
